IEV-407

N/A

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameIEV-407
Drug Alias NameIEV-407
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetastatic breast cancerHR-positive breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerHR-positive breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A